Researchers
Jukić, Marin
Type
Date issued
Date issued - custom
| Issue Date | Title | Author(s) | Type | М-cat. |
|---|---|---|---|---|
| 2024 | What is the Current Clinical Impact of the CYP2CTG Haplotype? (✓) | Ingelman-Sundberg, Magnus; Jukić, Marin   ; Bråten, Line Skute; Kringen, Marianne Kristiansen; Molden, Espen | Contribution to periodical | 21aM21a |
| 2023 | The humanised CYP2C19 transgenic mouse exhibits cerebellar atrophy and movement impairment reminiscent of ataxia | Milosavljević, Filip ; Brusini, Irene; Atanasov, Andrea ; Manojlović, Marina ; Vučić, Marija; Oreščanin-Dušić, Zorana ; Brkljačić, Jelena ; Miljević, Čedo; Nikolić-Kokić, Aleksandra ; Blagojević, Duško ;
Wang, Chunliang; Damberg, Peter; Pešić, Vesna
; Tyndale, Rachel F.; Ingelman-Sundberg, Magnus; Jukić, Marin ; | Article | 21aM21a |
| 2022 | The Polymorphic Nuclear Factor NFIB Regulates Hepatic CYP2D6 Expression and Influences Risperidone Metabolism in Psychiatric Patients | Lenk, Hasan Çağın; Klöditz, Katharina; Johansson, Inger; Løvsletten Smith, Robert; Jukić, Marin ; Molden, Espen; Ingelman-Sundberg, Magnus | Article | 21aM21a |
| 2022 | CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability (✓) | Joković, Danilo; Milosavljević, Filip ; Stojanović, Zvezdana ; Šupić, Gordana ; Vojvodić, Danilo ; Uzelac, Bojana; Jukić, Marin ; Petković Ćurčin, Aleksandra | Article | 21aM21a |
| 2022 | Pharmacogenomics in treatment of depression and psychosis: an update | Jukić, Marin ; Milosavljević, Filip ; Molden, Espen; Ingelman-Sundberg, Magnus | Article | 21aM21a |
| 2021 | Evaluation of the CYP2D6 Haplotype Activity Scores Based on Metabolic Ratios of 4,700 Patients Treated With Three Different CYP2D6 Substrates | Jukic, Marin M ; Smith, Robert Lovsletten; Molden, Espen; Ingelman-Sundberg, Magnus | Article | 21aM21a |
| 2021 | Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure: A Systematic Review and Meta-analysis (✓) | Milosavljevic, Filip ; Bukvić, Nikola ; Pavlović, Zorana Z. ; Miljević, Čedo D. ; Pešić, Vesna ; Molden, Espen; Ingelman-Sundberg, Magnus; Leucht, Stefan; Jukić, Marin M. | Article | 21aM21a |
| 2021 | A Novel CYP2C-Haplotype Associated With Ultrarapid Metabolism of Escitalopram | Braten, Line Skute; Haslemo, Tore; Jukic, Marin M ; Ivanov, Maxim; Ingelman-Sundberg, Magnus; Molden, Espen; Kringen, Marianne Kristiansen | Article | 21aM21a |
| 2020 | Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients | Braten, Line Skute; Haslemo, Tore; Jukic, Marin M ; Ingelman-Sundberg, Magnus; Molden, Espen; Kringen, Marianne Kristiansen | Article | 21aM21a |
| 2020 | Long-Term Effects of Maternal Deprivation on the Volume of Dopaminergic Nuclei and Number of Dopaminergic Neurons in Substantia Nigra and Ventral Tegmental Area in Rats (✓) | Kapor, Slobodan ; Aksić, Milan ; Puškaš, Laslo ; Jukić, Marin ; Poleksić, Joko ; Milosavljević, Filip ; Bjelica, Sunčica ; Filipović, Branislav | Article | 21aM21a |
| 2019 | Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study | Jukić, Marin ; Smith, Robert L.; Haslemo, Tore; Molden, Espen; Ingelman-Sundberg, Magnus | Article | 21aM21a |
| 2018 | Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients | Jukić, Marin ; Haslemo, Tore; Molden, Espen; Ingelman-Sundberg, Magnus | Article | 21aM21a |
| 2018 | BMP/SMAD pathway promotes neurogenesis of midbrain dopaminergic neurons in vivo and in human induced pluripotent and neural stem cells | Jovanović, V.M; Salti, A; Tilleman, H; Zega, K; Jukić, Marin ; Zou, H; Friedel, R.H; Prakash, N; Blaess, S; Edenhofer, F;
Brodski, C;
| Article | 21aM21a |
| 2015 | Abnormal development of monoaminergic neurons is implicated in mood fluctuations and bipolar disorder | Jukić, Marin ; Carrillo-Roa, T; Bar, M; Becker, G; Jovanović, V.M; Zega, K; Binder, E.B; Brodski, C | Article | 21aM21a |